Yutaka Takaoka

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Topics

Molecular Docking

Duchenne Muscular Dystrophy

Editorial Comment

Top Venues

Transgenic research

Nature genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Shigemi Kimura, Noriko Miyake, Shiro Ozasa, Hiroe Ueno, Yoshinobu Ohtani, Yutaka Takaoka, Ichizo Nishino
Increase in cathepsin K gene expression in Duchenne muscular dystrophy skeletal muscle. Neuropathology : official journal of the Japanese Society of Neuropathology (2024)
Xilin Wu, Elena Aisha Binti Azizan, Emily Goodchild, Sumedha Garg, Man Hagiyama, Claudia P Cabrera, Fabio L Fernandes-Rosa, Sheerazed Boulkroun, Jyn Ling Kuan, Zenia Tiang, Alessia David, Masanori Murakami, Charles A Mein, Eva Wozniak, Wanfeng Zhao, Alison Marker, Folma Buss, Rebecca S Saleeb, Jackie Salsbury, Yuta Tezuka, Fumitoshi Satoh, Kenji Oki, Aaron M Udager, Debbie L Cohen, Heather Wachtel, Peter J King, William M Drake, Mark Gurnell, Jiri Ceral, Ales Ryska, Muaatamarulain Mustangin, Yin Ping Wong, Geok Chin Tan, Miroslav Solar, Martin Reincke, William E Rainey, Roger Sik Yin Foo, Yutaka Takaoka, Sandra A Murray, Maria-Christina Zennaro, Felix Beuschlein, Akihiko Ito, Morris J Brown
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production. Nature genetics (2023)
Aki Sugano, Yutaka Takaoka, Haruyuki Kataguchi, Mika Ohta, Shigemi Kimura, Masatake Araki, Yoshitomo Morinaga, Yoshihiro Yamamoto
SARS-CoV-2 Omicron BA.2.75 Variant May Be Much More Infective than Preexisting Variants Based on In Silico Model. Microorganisms 10 (10) (2022)
Yutaka Takaoka, Mika Ohta, Satoshi Tateishi, Aki Sugano, Eiji Nakano, Kenji Miura, Takashi Suzuki, Chikako Nishigori
In Silico Drug Repurposing by Structural Alteration after Induced Fit: Discovery of a Candidate Agent for Recovery of Nucleotide Excision Repair in Xeroderma Pigmentosum Group D Mutant (R683W). Biomedicines 9 (3) (2021)
Tomohiko Yamamura, Tomoko Horinouchi, Tomomi Adachi, Maki Terakawa, Yutaka Takaoka, Kohei Omachi, Minoru Takasako, Kiyosumi Takaishi, Takao Shoji, Yoshiyuki Onishi, Yoshito Kanazawa, Makoto Koizumi, Yasuko Tomono, Aki Sugano, Akemi Shono, Shogo Minamikawa, China Nagano, Nana Sakakibara, Shinya Ishiko, Yuya Aoto, Misato Kamura, Yutaka Harita, Kenichiro Miura, Shoichiro Kanda, Naoya Morisada, Rini Rossanti, Ming Juan Ye, Yoshimi Nozu, Masafumi Matsuo, Hirofumi Kai, Kazumoto Iijima, Kandai Nozu
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5. Nature communications 11 (1) (2020)
Kandai Nozu, Yutaka Takaoka, Hirofumi Kai, Minoru Takasako, Kensuke Orito, Tomohiko Yamamura, Tomoko Horinouchi, Nana Sakakibara, Takeshi Ninchoji, China Nagano, Kazumoto Iijima
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome. Kidney research and clinical practice (2020)
Yutaka Takaoka, Atsuko Takeuchi, Aki Sugano, Kenji Miura, Mika Ohta, Takashi Suzuki, Daisuke Kobayashi, Takuji Kimura, Juichi Sato, Nobutaro Ban, Hisahide Nishio, Toshiyuki Sakaeda
Establishment of the experimental procedure for prediction of conjugation capacity in mutant UGT1A1. PloS one 14 (11) (2019)
Mika Ohta, Aki Sugano, Naoya Hatano, Hirotaka Sato, Hirofumi Shimada, Hitoshi Niwa, Toshiyuki Sakaeda, Hajime Tei, Yoshiyuki Sakaki, Ken-Ichi Yamamura, Yutaka Takaoka
Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis. Transgenic research 27 (1) (2017)